Tolerance Bio Secures $17.2 Million to Advance Immune Disease Therapies
PHILADELPHIA, PA — Tolerance Bio, Inc. has announced the recent closure of a $17.2 million seed financing round, surpassing its original funding goals. The round was led by Columbus Venture …
Tolerance Bio Secures $17.2 Million to Advance Immune Disease Therapies Read More